Voices
Case of a 62-Year-Old Woman With HER2+/HR− Breast Cancer – Dana-Farber’s Breast Oncology Center
Dana-Farber Cancer Institute/LinkedIn

Case of a 62-Year-Old Woman With HER2+/HR− Breast Cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

“Drs. Ada Waks and Sarah Sammons introduce a patient case of a 62‑year‑old woman with HER2+/HR- breast cancer.

They discuss how to select an optimal first‑line regimen for her amid an expanding range of therapeutic options. They review and compare data from the DESTINY‑Breast09 and phase 3 HER2CLIMB-05 trials, outlining evidence‑based treatment strategies for this clinical scenario.

Watch here.”

Dana-Farber’s Breast Oncology Center

Other articles about Dana-Farber’s Breast Oncology Center on OncoDaily.

Ada Waks Breast Cancer cancer Dana-Farber’s Breast Oncology Center DESTINY-Breast09 HER2CLIMB-05 OncoDaily Oncology Sarah Sammons